CPHI
China Pharma Holdings Inc
NYSE MKT: CPHI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.55
-0.16% today
Updated 2026-04-30
Market cap
$25.50M
P/E ratio
—
P/S ratio
6.15x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
China Pharma Holdings Inc (CPHI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
-31.3%
Most recent quarter
EPS YoY growth
+73.7%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.9%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-2.9%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-12 | $-0.17 | — | $1.57 | $1.52 | -2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.17 | — | $756217.00 | -31.3% |
| 2025-06-30 | $0.00 | $-0.16 | — | $1.03M | +10.9% |
| 2025-03-31 | — | $-0.24 | — | $1.14M | -17.0% |
| 2024-12-31 | — | $-0.53 | — | $1.13M | -47.2% |
| 2024-09-30 | — | $-0.65 | — | $1.10M | -39.0% |
| 2024-06-30 | — | $-0.89 | — | $924943.00 | -15.8% |
| 2024-03-31 | — | $-0.73 | — | $1.37M | — |
| 2023-12-31 | — | $-1.16 | — | $2.15M | — |
| 2023-09-30 | — | $-2.94 | — | $1.80M | — |
| 2023-06-30 | — | $-2.99 | — | $1.10M | — |
| 2023-03-31 | $0.00 | $-0.06 | — | — | — |
| 2022-12-31 | $0.00 | $-0.20 | — | — | — |
Frequently asked questions
Has China Pharma Holdings Inc beaten earnings estimates?
China Pharma Holdings Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does CPHI stock react to earnings?
CPHI stock has moved an average of -2.9% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.
What is China Pharma Holdings Inc's revenue growth rate?
China Pharma Holdings Inc reported year-over-year revenue growth of -31.3% in its most recent quarter, with EPS growing +73.7% year-over-year.